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Brief CommunicationsTranshiatal esophagogastrectomy for an isolated ovarian cancer
metastasis to the esophagus
John C. Haney, MD, and Thomas A. D’Amico, MD, Durham, NCSecondary involvement of the esophagus by malignancyis rare, occurring in patients with cancer at an estimatedincidence of 1% to 6%.1-3 Although primary cancers ofthe lung and breast are most commonly responsible,
other primary sites have included tumors of the prostate, skin,
kidney, bladder, rectum, pancreas, thyroid, liver, and endometri-
um.3,4 Esophageal metastasis from ovarian cancer has been re-
ported in only 1 case, in which the metastasis occurred 16 years
after initial tumor resection and was treated with partial esopha-
gectomy.1,2 This report describes a case of metastatic ovarian
cancer to the esophagus after a 4-year disease-free interval.
Clinical Summary
A 58-year-old woman had a 2-month history of dysphagia. Four
years previously, she had undergone complete resection of a 21-cm
clear cell ovarian neoplasm with positive bilateral pelvic and
periaortic lymph nodes, followed by chemotherapy. Computed
tomographic scan 1 year after surgery demonstrated no progres-
sion, and the patient remained free of symptoms until the dyspha-
gia developed.
A computed tomographic scan obtained at that time revealed a
mass in the midesophagus (Figure 1), and esophageal ultrasonog-
raphy demonstrated a partially obstructing tumor that appeared to
involve the submucosa. A biopsy sample demonstrated adenocar-
cinoma, consistent with ovarian metastases. The patient underwent
positron emission tomography, which revealed no extrathoracic
disease. After multidisciplinary consultation, the decision was
made to undertake surgical resection, to be followed by adjuvant
chemotherapy.
During the operation, the tumor appeared to be adherent to but
not invasive of the aorta and was mobilized without difficulty.
Examination of the liver, diaphragm, and peritoneum revealed no
evidence of metastatic disease. Transhiatal resection with cervical
esophagogastric anastomosis was performed without difficulty.
The patient was discharged without complication on postoperative
day 7.
Pathologic examination of the specimen revealed a 7-cm
midesophageal mass, with invasion into the muscularis. All sur-
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positive. The tumor was characterized as ovarian adenocarcinoma,
clear cell variant. It demonstrated immunoreactivity to CA-125,
cytokeratin 7, and carcinoembryonic antigen but not cytokeratin
20. Both the histologic and immunoreactivity profiles were iden-
tical to those of the patient’s previous ovarian carcinoma, and a
diagnosis of metastatic ovarian carcinoma was confirmed.
Discussion
Metastases to the esophagus are rare, estimated to occur in 1% of
patients with cancer.2,3 Our case appears to be only the second
reported case of metastasis to the esophagus from ovarian carci-
noma.1,2 A review of 62 cases of secondary esophageal neoplasms
estimated that 45% were the result of direct extension, 36% were
due to lymphatic spread from mediastinal nodes, and 19% oc-
curred from hematogenous seeding.4 Ovarian cancers are notori-
ous for early metastasis, and spread to the thoracic cavity is
relatively common, with incidence estimates ranging from 7% to
44.5% of patients with ovarian cancer, although thoracic involve-
ment without liver metastases occurs only 3% of the time.2,5
Treatment of esophageal metastases is difficult, especially in
cases of direct extension or lymphatic invasion. In most cases,
patients are treated with palliative radiation or chemotherapy. In
Figure 1. Computed tomographic scan demonstrates mass in
midesophagus, without evidence of involvement of aorta or air-
way.some cases, however, especially those in which a solitary metas-
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Brief Communicationstasis is encountered, the lesion may be amenable to surgical
resection.6 Fujii and colleagues6 have advocated the resection of
solitary breast cancer metastases followed by chemotherapy when
local control may be achieved, and when the disease-free interval
has been long, indicative of a slow-growing primary tumor. Oka
and associates7 reported on resection of a metastasis from a lung
cancer primary after a latency period of 5 years; the patient
remained without recurrence 23 months after resection. Mizobuchi
and colleagues2 reported on 3 cases of esophagectomy, including
the one previous patient with an ovarian cancer metastasis; long-
term survivals of 4 and 14 years were achieved in patients in which
the disease-free intervals had been 7 and 16 years, respectively.
In the case of our patient, the solitary esophageal metastasis
was seen after a disease-free interval of approximately 4 years.
Positron emission tomographic scan did not detect extrathoracic
disease, and local control of the tumor appeared achievable. Be-
cause of the patient’s age and relative health, resection followed by
adjuvant therapy was pursued. The choice to perform resection
before chemotherapy is consistent with the strategy to perform
surgical debulking before systemic therapy for ovarian cancer;
however, the use of preoperative chemotherapy followed by sur-
gical resection would seem to be equally feasible. Although the
ultimate prognosis of esophageal metastases is poor, effective
symptom resolution and long-term disease-free interval are achiev-
able goals for resection. Appropriate patients would include thosePisa, Italy
1836 The Journal of Thoracic and Cardiovascular Surgery ● Junin sufficiently good preoperative health with solitary metastasis
from slow-growing tumors, as evidenced by a relatively long
symptom-free interval. For effective resection with an acceptable
level of morbidity, the transhiatal approach is advocated.
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cancer. Cancer. 1993;71:2958-61.Massive pneumoencephalus of late onset after an en bloc resection for
lung cancer
Marco Lucchi, MD, Paolo Dini, MD, Francesco Givigliano, MD, Alessandro Ribechini, MD, and Alfredo Mussi, MD,Extended resections are considered a valid therapeuticoption in cases of selected locally advanced lung cancerin reason of an acceptable morbidity.1-3 Multimodalitytreatment, including chemotherapy, radiotherapy, and
surgical intervention, has proved to improve the results in terms of
disease-free and overall survival,4-6 despite a major postoperative
morbidity.7
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doi:10.1016/j.jtcvs.2004.01.019Pneumoencephalus is a rare complication of important cranial
trauma8 or neurosurgery,9 but to our knowledge, it was never
reported after thoracic surgery. We report a case of massive
pneumoencephalus appearing late after an en bloc upper right
lobectomy for lung cancer in a patient who previously underwent
chemoradiotherapy. Thoracic surgeons should be aware of this
possible complication when an extended lung resection involving
the ribs and the vertebral bodies is performed.
Clinical Summary
A 76-year-old man was referred for surgical treatment of right
upper lobe squamous carcinoma infiltrating the chest wall. Previ-
ously, the patient underwent 3 cycles of neoadjuvant chemother-
apy (carboplatin and paclitaxol) and radiotherapy (40 Gy) with a
partial response (50%). At the operation, we performed an en
bloc right upper lobectomy with the posterior arches of the first 4
ribs and the transverse process of D2.
The postoperative course was uneventful, and the patient was
discharged on the ninth day. The pathologic examination showed
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